|
|
||||||||
Ann Thorac Surg 2001;72:793-797
© 2001 The Society of Thoracic Surgeons
a Department of Surgery, Cardiothoracic Division, Albert Einstein Medical Center, Jefferson Health System, Philadelphia, Pennsylvania, USA
Accepted for publication May 15, 2001.
Address reprint requests to Dr Quigley, Division of Cardiothoracic Surgery, Albert Einstein Medical Center, 5501 Old York Rd, HB-3, Philadelphia, PA 19141
e-mail: quigleyr{at}aehn2.einstein.edu
| Abstract |
|---|
|
|
|---|
Methods. We performed 321 off-pump coronary artery bypass operations, of which, 290 (90%) were done with only arterial conduits. The mean number of distal anastomoses was 2.48, with a range of 1 to 5. There were no aortic anastomoses. One hundred eighty-nine patients (65%) were male, and 101 (35%) were female, with a mean age of 67 years. Comorbidities included chronic renal failure (CRF), 21 (7%); diabetes, 92 (32%); obesity, 68 (23%); hypertension, 212 (73%); chronic obstructive pulmonary disease, 189 (65%); cerebral vascular accident (CVA), 39 (13%); smoking, 164 (56%); and hypercholesterolemia, 151 (52%). The mean ejection fraction was 56%, with a range of 21% to 71%. All procedures were performed with external stabilizers with or without vacuum assist. The complete arterial revascularizations included a T-graft (internal thoracic [ITA]/radial arteries [RA]), 130 (45%); a sequential graft (ITA ± RA), 118 (41%); a U-graft (coronary-coronary graft perfused by the ITA or right gastroepiploic artery), 5 (2%); an I-graft (ITA/RA), 4 (1%); an X-graft (ITA/RA), 2 (12); and a Y-graft (ITA/RA), 31 (10%).
Results. The postoperative incidence of atrial fibrillation was 80 of 290 (27%); CVA, 5 of 290 (2%); bleeding resulting in take-back, 5 of 290 (2%); CRF, 8 of 290 (3%); deep sternal infection, 4 of 290 (1%); and readmission (30-day) for angina, 4 of 290 (1%). The observed perioperative (30-day) mortality was 9 of 290 (3.1%), with the STS predicted rate of 3.82%.
Conclusions. Our experience indicates that once the operating surgeon has learned to safely expose the lateral and inferior walls of the heart, the type of conduit and the method of revascularization should be no different than that used with cardiopulmonary bypass. However, we still recommend conventional methods of revascularization (on-pump with saphenous vein conduits) for the ischemic patient.
| Introduction |
|---|
|
|
|---|
Unfortunately, some clinicians remain skeptical about technical limitations of the OPCAB operation and the long-term patency of the anastomoses [5]. This skepticism has, in most centers, delayed progress in beating heart surgery, which typically is performed using the standard (historic) conduits (left internal thoracic artery [LITA] and reversed saphenous vein) in the routine configuration. In our program, not only did we question the use of CPB, but we also questioned the choice and configuration of our conduits.
New technology/skills for conduit harvest [6], potent vasodilators, and long-term patency data have resulted in a renewed interest in arterial conduits [7]. We share this interest, and over the last several years have developed unique methods to revascularize the myocardium using only arterial conduits. Here we report our recent series of OPCAB surgical procedures where total myocardial revascularization was performed with arterial conduits.
| Material and methods |
|---|
|
|
|---|
|
Arterial revascularization was achieved using either a sequential graft(s) (Fig 1), or a composite graft (Figs 2 to 6). The principles and technique of sequential grafting were extrapolated from our previous series of sequential vein grafting [9]. Two hundred seventy-eight of the operations were performed via a median sternotomy, six through a left lateral thoracotomy, and six through an anterior thoracotomy (MIDCAB) incision.
|
|
|
|
|
|
| Results |
|---|
|
|
|---|
|
Only four of the deaths were in-hospital, and they were all severely moribund at the time of operation and each succumbed to multisystem organ failure. Although there was no evidence of cardiac ischemia postoperatively, they all suffered from states of low cardiac output. Three of the other five mortalities were sudden and occurred either at home or in convalescent homes. In the absence of autopsy data, it is unclear whether these represented fatal cardiac dysrhythmias or pulmonary emboli. The remaining two had cerebral vascular accidents (CVAs) from which they did not recover.
| Comment |
|---|
|
|
|---|
The concept of composite arterial grafting is not novel, however, the application of this technique to the beating heart is unique. Ever since the left ITA has been documented to be associated with increased survival, surgeons have devised and applied new methods of arterial revascularization [11]. Complete myocardial revascularization with a ITA-ITA T-graft [12, 13] and ITA-RA Y-graft [14] have already been reported. Additionally, coronary artery bypass grafting with an RGEA composite graft has also been described [15]. Recent data indicate that creation of a composite graft does not compromise blood flow in either limb of the graft but rather increases proximal flow rates, indicating, at least in the ITA, there is a flow reserve [16].
We are satisfied with our exposure for this procedure using either the median sternotomy or lateral thoracotomy approach, depending on the coronary anatomy. Our interest in the use of the MIDCAB incision has waned, as we have not been able to demonstrate any advantage over the other two approaches, and in fact, we have observed more wound-related problems [17].
Our observed incidence of permanent stroke (CVA) of 2% (5 of 290) was no different than the predicted value but nevertheless suprisingly high considering the absence of aortic manipulation/instrumentation. The wide spectrum of neurocognitive dysfunction, after conventional CABG [18], has been attributed to CPB and resultant air/debris emboli, however, we are now trying to determine whether the mechanism of CVA in our series is different. Presently, it is unclear whether these unfortunate patients developed a state of hypercoagulability, which, when superimposed on a substrate of cerebrovascular atherosclerosis, resulted in CVA. We have not yet begun empiric anticoagulation therapy with agents other than aspirin in our postoperative protocols until further scientific data are available.
It also should be noted that our mortality of 3.1% (9 of 290) was only slightly less than the expected using the STS database (3.82%). It may not be an accurate comparison because the STS data are based on a similar population of patients where CPB was instituted.
The incidence of atrial fibrillation was certainly higher than the STS expected value (27% vs 20.8%). This result is curious because the lack of instrumentation of the heart in the OPCAB patient should theoretically reduce the amount of cardiac trauma. These results therefore support the concept that postoperative atrial fibrillation is multifactorial and not solely related to trauma [19].
As our experience has evolved, we now find few if any contraindications to the OPCAB operation. We even have our own small series of successful reoperative procedures performed on the beating heart as previously demonstrated by others (not included in this series) [20]. Ongoing ischemia as manifested by electrocardiographic changes remains the only relative contraindication to complete arterial OPCAB surgery. In these rare cases, we are inclined to use both venous conduit and CPB.
Although the harvest and preparation of arterial grafts is labor intensive, we strongly believe that they represent the conduits of choice for patients in the new millennium. It is unclear whether our low 30-day readmission rate for angina, when compared with the STS database (1% vs 5.7%), is due to our choice of conduits or the beating heart approach. Hopefully, our long-term data, which we are presently collecting, will allow us to separate these issues. Finally, we support the concept that beating heart surgery is not a "passing trend" but rather in most circumstances the preferred method of coronary revascularization [18], and we now perform over 85% of our CABGs without CPB. Intramyocardial coronaries, ventricular dysfunction, atrial fibrillation, cardiomegaly, and repeat sternotomy, no longer, in our practice, contraindicate beating heart surgery.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. M. Dewey and M. J. Mack Myocardial Revascularization without Cardiopulmonary Bypass , January 1, 2008; 3(2008): 633 - 654. [Full Text] |
||||
![]() |
T. Fukui, S. Takanashi, Y. Hosoda, and S. Suehiro In situ bilateral skeletonized internal thoracic arterial grafting for left-side myocardial revascularization using an off-pump technique Interact CardioVasc Thorac Surg, August 1, 2006; 5(4): 413 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukui, S. Takanashi, Y. Hosoda, and S. Suehiro Total Arterial Myocardial Revascularization Using Composite and Sequential Grafting With the Off-Pump Technique Ann. Thorac. Surg., August 1, 2005; 80(2): 579 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Sajja, G. Mannam, N. R. Pantula, and S. Sompalli Role of Radial Artery Graft in Coronary Artery Bypass Grafting Ann. Thorac. Surg., June 1, 2005; 79(6): 2180 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kamiya, G. Watanabe, H. Takemura, S. Tomita, H. Nagamine, and T. Kanamori Total arterial revascularization with composite skeletonized gastroepiploic artery graft in off-pump coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Ngaage Off-pump coronary artery bypass grafting: the myth, the logic and the science Eur J Cardiothorac Surg, October 1, 2003; 24(4): 557 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Dewey and M. J. Mack Myocardial Revascularization Without Cardiopulmonary Bypass , January 1, 2003; 2(2003): 609 - 625. [Full Text] |
||||
![]() |
R L Quigley, D W Fried, R Salenger, J Pym, and R Y Highbloom Thrombelastographic changes in OPCAB surgical patients Perfusion, September 1, 2002; 17(5): 363 - 367. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |